Clinical Trial Update: Effect of Opioid Infusion Rate on Abuse Liability Potential of Intravenous Hydromorphone for Cancer Pain [Phase 4]

View source ↗

Summary

Phase 4 trial assessing whether the rate of intravenous hydromorphone infusion affects abuse liability in cancer pain patients; status is active but not recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Hematopoietic and Lymphoid Cell Neoplasm
• Malignant Solid Neoplasm

Drugs mentioned

• Hydromorphone (hydromorphone)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm | Phase 4 | Status: ACTIVE_NOT_RECRUITING